Out FoxO'd by microRNA. Focus on "miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle"

American Journal of Physiology - Cell Physiology

Volumn 307, Issue 4, 2014, Pages

  McCarthy, John J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; DEXAMETHASONE; MICRORNA 1; MICRORNA 182; MUSCLE RING FINGER 1 PROTEIN; TRANSCRIPTION FACTOR FKHRL1;

AUTOPHAGY; DIABETES MELLITUS; EDITORIAL; GENE OVEREXPRESSION; GENE SEQUENCE; GENE TARGETING; IN VITRO STUDY; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA DEGRADATION; RNA SEQUENCE; RNA TRANSLATION; UPREGULATION;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; MALE; MICRORNAS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MYOBLASTS, SKELETAL;

EID: 84907671625     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00219.2014     Document Type: Editorial

References (15)

1. Allen DL, Loh AS. Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am J Physiol Cell Physiol 300: C124-C137, 2010.
2. Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157: 77-94, 2014.
3. Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell 149: 515-524, 2012.
4. Erhard F, Haas J, Lieber D, Malterer G, Jaskiewicz L, Zavolan M, Dolken L, Zimmer R. Widespread context dependency of microRNAmediated regulation. Genome Res 24: 906-919, 2014.
5. Foletta VC, White LJ, Larsen AE, Leger B, Russell AP. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflügers Arch 461: 325-335, 2011.
6. Hudson MB, Rahnert JA, Zheng B, Woodworth-Hobbs ME, Franch HA, Price SR. miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle. Am J Physiol Cell Physiol (May 28, 2014). doi: 10.1152/ajpcell.00395.2013.
7. Kirby TJ, McCarthy JJ. MicroRNAs in skeletal muscle biology and exercise adaptation. Free Radic Biol Med 64: 95-105, 2013.
8. Kukreti H, Amuthavalli K, Harikumar A, Sathiyamoorthy S, Feng PZ, Anantharaj R, Tan SL, Lokireddy S, Bonala S, Sriram S, McFarlane C, Kambadur R, Sharma M. Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasonemediated atrophy. J Biol Chem 288: 6663-6678, 2013.
9. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739, 2002.
10. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412, 2004.
11. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, Osman I, Hernando E. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 106: 1814-1819, 2009.
12. Senf SM, Dodd SL, Judge AR. FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70. Am J Physiol Cell Physiol 298: C38-C45, 2010.
13. Soares RJ, Cagnin S, Chemello F, Silvestrin M, Musaro A, De Pitta C, Lanfranchi G, Sandri M. Involvement of miRNAs in the regulation of muscle wasting during catabolic conditions. J Biol Chem doi: 10.1074/ jbc.M114.561845 [Epub ahead of print].
14. Wada S, Kato Y, Okutsu M, Miyaki S, Suzuki K, Yan Z, Schiaffino S, Asahara H, Ushida T, Akimoto T. Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy. J Biol Chem 286: 38456-38465, 2011.
15. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6: 472-483, 2007.